Posted inMergers & Acquisitions, Oncology Takeda Bets on Promising Gamma Delta T-cell Immunotherapy October 28, 2021September 8, 2022 UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.
